Paul K Wotton's Net Worth

$6.55 Million

Estimate Recalculated Nov 1, 2024 10:01AM EST

Who is Paul K Wotton

Paul K Wotton has an estimated net worth of $6.55 Million. This is based on reported shares across multiple companies, which include Vericel Corp, ANTARES PHARMA INC, Ocata Therapeutics, Inc., and GENAERA CORP.

SEC CIK

Paul K Wotton's CIK is 0001300997

Past Insider Trading and Trends

2013 was Paul K Wotton's most active year for acquiring shares with 12 total transactions. Paul K Wotton's most active month to acquire stocks was the month of April. 2013 was Paul K Wotton's most active year for disposing of shares, totalling 18 transactions. Paul K Wotton's most active month to dispose stocks was the month of December. 2021 saw Paul K Wotton paying a total of $637,612.50 for 54,600 shares, this is the most they've acquired in one year. In 2016 Paul K Wotton cashed out on 577,500 shares for a total of $2,358,750.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vericel Corp

Investor
Updated May 03, 2024
Form 4
74.57%
17.60K
May 03, 2024
41.20K
Options
May 01
Form 4
-15.72%
-5.00K
$37.31
-$186.55K
Dec 15, 2023
26.80K
Sale
Dec 14
Form 4
11.20K
May 05, 2023
11.20K
Grant
May 03
Form 4
Apr 28, 2023
31.80K
Options
Apr 27
Form 4
31.16%
9.10K
Apr 29, 2022
38.30K
Options
Apr 27
Form 4
-15.82%
-5.00K
$50.52
-$252.61K
May 17, 2021
26.60K
Sale
May 14
Form 4
-33.12%
-15.65K
$32.25
-$143.84K
May 13, 2021
31.60K
Sale
May 11 - May 12
Form 4
260.00%
9.10K
Apr 30, 2021
12.60K
Options
Apr 28
Form 4
850.00%
14.88K
$14.56
-$25.48K
May 01, 2020
16.63K
Options
Apr 29
Form 4
14.88K
May 03, 2019
14.88K
Grant
May 01
Form 4
-100.00%
-22.50K
$9.74
-$318.87K
Jan 04, 2019
Sale
ScheduledJan 02
Form 4
-85.71%
-30.00K
$7.74
-$259.40K
Jun 20, 2018
5.00K
Sale
ScheduledJun 18
Form 4
17.50K
May 03, 2018
17.50K
Grant
May 02
Form 4
17.50K
May 05, 2017
17.50K
Grant
May 03
Form 4
15.00K
May 06, 2016
15.00K
Grant
May 04
Form 3/A
Aug 28, 2015
Form 4
20.00K
Mar 24, 2015
20.00K
Grant
Mar 20
Form 3
Jan 07, 2015
Showing 18 results

ANTARES PHARMA INC

President and CEO
Updated Jun 02, 2014
Form 4
20.20%
421.82K
Jun 02, 2014
2.51M
Grant
May 29
Form 4
1.05%
7.00K
$4.85
-$16.05K
Feb 24, 2014
670.73K
Grant
Feb 20
Form 4
-6.35%
-45.00K
$4.45
-$48.95K
Feb 13, 2014
663.73K
Disposition
Feb 11
Form 4
-1.07%
-22.90K
$2.80
-$105.31K
Jan 17, 2014
2.13M
Sale
ScheduledJan 15
Form 4
-2.90%
-64.10K
$2.25
-$224.59K
Dec 10, 2013
2.15M
Sale
ScheduledDec 06 - Dec 09
Form 4
-1.56%
-35.00K
$2.35
-$129.01K
Oct 03, 2013
2.21M
Sale
ScheduledOct 01
Form 4
-1.53%
-35.00K
$2.46
-$136.88K
Sep 05, 2013
2.25M
Sale
ScheduledSep 03
Form 4
-1.51%
-35.00K
$2.46
-$137.09K
Aug 05, 2013
2.28M
Sale
ScheduledAug 01
Form 4
-1.49%
-35.00K
$2.32
-$127.47K
Jul 03, 2013
2.32M
Sale
ScheduledJul 01
Form 4
-5.04%
-125.00K
$2.26
-$438.64K
Jun 05, 2013
2.35M
Sale
ScheduledJun 03
Form 4
16.38%
348.88K
May 24, 2013
2.48M
Grant
May 22
Form 4
-0.47%
-10.00K
$2.27
-$35.35K
May 08, 2013
2.13M
Sale
ScheduledMay 06
Form 4
-1.15%
-25.00K
$2.26
-$87.80K
Jan 10, 2013
2.15M
Sale
ScheduledJan 08
Form 4
-1.13%
-25.00K
$2.25
-$87.51K
Dec 06, 2012
2.18M
Sale
ScheduledDec 04
Form 4
8.10%
165.07K
Jul 10, 2012
2.20M
Grant
Jul 06
Form 4
10.67%
150.00K
May 21, 2012
1.56M
Grant
May 17
Form 4
1.46%
6.95K
Feb 13, 2012
482.62K
Grant
Feb 10
Form 4
10.49%
45.16K
Sep 13, 2011
475.67K
Grant
Sep 09
Form 4
11.20%
186.00K
May 19, 2011
1.85M
Grant
May 17
Form 4
4.89%
17.37K
Apr 11, 2011
372.68K
Grant
Apr 07
Form 4
17.36%
52.55K
Mar 01, 2011
355.31K
Grant
Feb 25
Form 4
13.19%
150.00K
Nov 15, 2010
1.29M
Grant
Nov 11
Form 4
3.30%
10.00K
$1.50
$15.00K
Aug 24, 2010
312.94K
Purchase
Aug 24
Form 4
21.62%
53.85K
Feb 24, 2010
302.94K
Grant
Feb 22
Form 4
14.44%
175.00K
Nov 13, 2009
1.39M
Grant
Nov 12
Form 4
28.72%
50.00K
Aug 14, 2009
224.09K
Grant
Aug 12
Form 4
12.98%
20.00K
$0.40
$8.05K
Mar 31, 2009
174.09K
Purchase
Mar 30
Form 4
19.37%
25.00K
$0.48
$12.00K
Nov 19, 2008
154.09K
Purchase
Nov 17
Form 4
90.82%
470.00K
Oct 21, 2008
987.50K
Grant
Oct 20
Form 4
341.09%
500.00K
Aug 07, 2008
646.59K
Grant
Aug 06
Form 4
34.29%
30.00K
May 16, 2008
117.50K
Grant
May 14
Form 4
195.46%
39.09K
May 14, 2007
59.09K
Grant
May 10
Form 4
10.00K
May 05, 2006
10.00K
Grant
May 03
Form 4
266.67%
20.00K
$1.54
$30.80K
Jan 05, 2006
27.50K
Grant
Jan 03
Form 4
20.00K
$1.40
$28.00K
Jan 04, 2005
2.50K
Grant
Jan 03
Form 4
5.00K
$1.40
$7.00K
Oct 25, 2004
Grant
Oct 25
Form 3
Aug 20, 2004
20.00K
Showing 37 results

Ocata Therapeutics, Inc.

President and CEO
Updated Feb 11, 2016
Form 4
-100.00%
-577.50K
$8.50
-$2.36M
Feb 11, 2016
Disposition
Feb 10
Form 4
-10.83%
-32.50K
$4.23
-$137.47K
Jul 31, 2015
267.50K
Tax
Jul 30
Form 4
3.33%
10.00K
Mar 09, 2015
310.00K
Grant
Mar 05
Form 4
60.00M
Jul 31, 2014
60.00M
Grant
Jul 30
Form 3
Jul 24, 2014
Showing 5 results

GENAERA CORP

Investor
Updated Aug 15, 2008
Form 4
17.50K
Aug 15, 2008
17.50K
Grant
Aug 13
Form 4
3.33K
Jun 30, 2008
3.33K
Grant
Jun 26
Form 3
Jun 30, 2008
Showing 3 results